Page last updated: 2024-08-23

danazol and Dysmyelopoietic Syndromes

danazol has been researched along with Dysmyelopoietic Syndromes in 26 studies

Research

Studies (26)

TimeframeStudies, this research(%)All Research%
pre-19905 (19.23)18.7374
1990's12 (46.15)18.2507
2000's5 (19.23)29.6817
2010's2 (7.69)24.3611
2020's2 (7.69)2.80

Authors

AuthorsStudies
Gu, X; He, J; Li, F; Lin, Y1
Garcia-Horton, A; Lazo-Langner, A; Valliere, Y1
Cantú-Rodríguez, OG; Colunga-Pedraza, JE; Colunga-Pedraza, PR; Garza-Ledezma, MA; Gómez-Almaguer, D; Gómez-De León, A; Gutiérrez-Aguirre, CH; Jaime-Pérez, JC; López-García, YK; Lozano-Morales, RE; Rendón-Ramírez, EJ; Sotomayor-Duque, G1
Choi, EJ; Jeon, M; Kang, H; Kang, YA; Lee, JH; Lee, KH; Lee, YS; Park, HS; Seol, M; Woo, JM1
Chan, G; DiVenuti, G; Miller, K1
Hehlmann, R; Lengfelder, E1
Krook, JA; Letendre, L; Levitt, R; Mailliard, JE; Morton, RF; Pierre, RV; Schroeder, G; Tschetter, LK1
Avilés, A1
Bauters, F; Cambier, N; Caulier, MT; Fenaux, P; Sautière, D; Wattel, E1
Bost, M; Chabannon, C; Hollard, D; Léger, J; Molina, L; Pégourié-Bandelier, B1
Catalano, L; Fontana, R; Formisano, S; Fratellanza, G; Montuori, N; Notaro, R; Rotoli, B; Selleri, C1
Bauters, F; Caulier, MT; Fenaux, P; Hebbar, M; Kaplan, C; Morel, P; Wattel, E; Wetterwald, M1
Ezaki, K; Hirano, M; Ino, T; Okamoto, M; Tsuzuki, M; Yamaguchi, T1
Cosson, A; Fenaux, P; Grardel, N; Lepelley, P; Poulain, S; Preudhomme, C1
Fernandez, L; Hayne, O; Sadek, I; Zayed, E1
Bauters, F; Bourgeois, E; Caulier, MT; Dupriez, B; Fenaux, P; Rose, C1
Chatzidimitriou, G; Loukopoulos, D; Meletis, J; Plata, E; Terpos, E; Vaiopoulos, G; Variami, E; Viniou, N; Yataganas, X1
Canioni, D; Damaj, G; Hermine, O; Lefrère, F; Radford-Weiss, I; Rubio, MT; Valensi, F; Varet, B1
Noël, P; Solberg, LA1
Hotta, T1
Catalano, L; De Rosa, G; Fontana, R; Notaro, R; Rotoli, B; Selleri, C1
Barbui, T; Bassan, R; Marini, B1
Buzaid, AC; Durie, BG; Garewal, HS; Greenberg, BR; Katakkar, SB; Lippman, SM1
Buzaid, AC; Garewal, HS; Greenberg, BR1
Martín Casellas, E; Salinas Argente, R; Sans-Sabrafen, J1
Iuklea, S; Kaufman, S; Kornberg, A; Yona, R1

Reviews

4 review(s) available for danazol and Dysmyelopoietic Syndromes

ArticleYear
Anabolic steroids in myelodysplastic syndromes: A systematic review.
    Leukemia research, 2020, Volume: 94

    Topics: Danazol; Humans; Myelodysplastic Syndromes; Testosterone Congeners

2020
Myelodysplastic syndromes. Pathogenesis, diagnosis and treatment.
    Critical reviews in oncology/hematology, 1992, Volume: 12, Issue:3

    Topics: Antineoplastic Agents; Biomarkers; Bone Marrow Transplantation; Calcitriol; Combined Modality Therapy; Danazol; Diagnosis, Differential; Glucocorticoids; Hematopoietic Cell Growth Factors; Humans; Immunologic Factors; Incidence; Interferons; Myelodysplastic Syndromes; Prognosis; Recombinant Proteins; Tretinoin

1992
[Management of myelodysplastic syndromes].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1990, Volume: 31, Issue:4

    Topics: Bone Transplantation; Cholecalciferol; Colony-Stimulating Factors; Cytarabine; Danazol; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Growth Substances; Humans; Immunologic Factors; Isotretinoin; Myelodysplastic Syndromes

1990
Management of myelodysplastic syndromes.
    The American journal of medicine, 1986, Volume: 80, Issue:6

    Topics: Androgens; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cytarabine; Danazol; Glucocorticoids; Humans; Isotretinoin; Myelodysplastic Syndromes; Pyridoxal Phosphate; Pyridoxine; Tretinoin

1986

Trials

6 trial(s) available for danazol and Dysmyelopoietic Syndromes

ArticleYear
Myelodysplastic syndrome treatment with danazol and cis-retinoic acid.
    American journal of hematology, 1995, Volume: 48, Issue:4

    Topics: Aged; Cross-Over Studies; Danazol; Drug Administration Schedule; Female; Humans; Male; Myelodysplastic Syndromes; Prospective Studies; Tretinoin

1995
Androgen therapy in myelodysplastic syndromes with thrombocytopenia: a report on 20 cases.
    British journal of haematology, 1994, Volume: 87, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Danazol; Female; Fluoxymesterone; Hemoglobins; Humans; Leukocyte Count; Male; Middle Aged; Myelodysplastic Syndromes; Neutrophils; Pilot Projects; Platelet Count; Thrombocytopenia

1994
A review of 76 patients with myelodysplastic syndromes treated with danazol.
    Cancer, 1994, Jun-15, Volume: 73, Issue:12

    Topics: Adult; Aged; Aged, 80 and over; Anemia, Refractory; Anemia, Refractory, with Excess of Blasts; Anemia, Sideroblastic; Autoantibodies; Blood Cell Count; Blood Platelets; Blood Transfusion; Danazol; Female; Humans; Male; Middle Aged; Myelodysplastic Syndromes; Retrospective Studies

1994
Expression of lung resistance protein and correlation with other drug resistance proteins and outcome in myelodysplastic syndromes.
    Leukemia & lymphoma, 1998, Volume: 29, Issue:5-6

    Topics: Acute Disease; Antibiotics, Antineoplastic; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cytarabine; Danazol; Disease Progression; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Gene Expression Regulation; Hematopoietic Stem Cells; Humans; Karyotyping; Leukemia, Myeloid; Leukemia, Myelomonocytic, Chronic; Life Tables; Myelodysplastic Syndromes; Neoplasm Proteins; Proto-Oncogene Proteins c-bcl-2; Quinine; Survival Analysis; Treatment Outcome; Tumor Suppressor Protein p53; Vault Ribonucleoprotein Particles

1998
Danazol therapy for thrombocytopenia in patients with myelodysplastic syndromes.
    Acta haematologica, 2002, Volume: 107, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Danazol; Female; Humans; Male; Middle Aged; Myelodysplastic Syndromes; Platelet Count; Thrombocytopenia; Treatment Outcome

2002
Danazol in the treatment of myelodysplastic syndromes.
    European journal of haematology, 1987, Volume: 39, Issue:4

    Topics: Clinical Trials as Topic; Danazol; Female; Humans; Male; Myelodysplastic Syndromes; Pregnadienes

1987

Other Studies

16 other study(ies) available for danazol and Dysmyelopoietic Syndromes

ArticleYear
Rare Pattern of Myelodysplastic Syndrome (MDS) with Serum Monoclonal Immunoglobulin: Case Report.
    Alternative therapies in health and medicine, 2023, Volume: 29, Issue:3

    Topics: Danazol; Dexamethasone; Humans; Male; Myelodysplastic Syndromes; Plasmacytoma; Thalidomide

2023
Danazol as First-Line Therapy for Myelodysplastic Syndrome.
    Clinical lymphoma, myeloma & leukemia, 2018, Volume: 18, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Danazol; Estrogen Antagonists; Female; Gastrointestinal Diseases; Humans; Male; Middle Aged; Myelodysplastic Syndromes; Retrospective Studies; Survival Analysis; Treatment Outcome; Weight Gain

2018
Androgen therapy for patients with lower-risk myelodysplastic syndrome and significant cytopenia: a retrospective study.
    British journal of haematology, 2019, Volume: 187, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Androgens; Danazol; Female; Humans; Male; Middle Aged; Myelodysplastic Syndromes; Oxymetholone; Retrospective Studies; Thrombocytopenia; Treatment Outcome; Young Adult

2019
Danazol for the treatment of thrombocytopenia in patients with myelodysplastic syndrome.
    American journal of hematology, 2002, Volume: 71, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Androgens; Danazol; Female; Humans; Male; Middle Aged; Myelodysplastic Syndromes; Platelet Count; Retrospective Studies; Thrombocytopenia; Time Factors

2002
[Treatment of myelodysplastic syndromes aside from clinical studies].
    Deutsche medizinische Wochenschrift (1946), 1995, Nov-03, Volume: 120, Issue:44

    Topics: Age Factors; Aged; Danazol; Erythrocyte Transfusion; Estrogen Antagonists; Female; Humans; Myelodysplastic Syndromes; Platelet Transfusion; Prognosis; Pyridoxine

1995
A review of 76 patients with myelodysplastic syndromes treated with danazol.
    Cancer, 1995, Jan-01, Volume: 75, Issue:1

    Topics: Controlled Clinical Trials as Topic; Danazol; Double-Blind Method; Humans; Myelodysplastic Syndromes

1995
Danazol for myelodysplastic syndromes.
    British journal of haematology, 1993, Volume: 85, Issue:1

    Topics: Blood Cell Count; Blood Platelets; Danazol; Humans; Myelodysplastic Syndromes

1993
Low incidence of specific anti-platelet antibodies detected by the MAIPA assay in the serum of thrombocytopenic MDS patients and lack of correlation between platelet autoantibodies, platelet lifespan and response to danazol therapy.
    British journal of haematology, 1996, Volume: 94, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Autoantibodies; Blood Platelets; Child; Child, Preschool; Danazol; Female; Humans; Immunoglobulin G; Infant; Male; Middle Aged; Myelodysplastic Syndromes; Prospective Studies; Thrombocytopenia

1996
[Myelodysplastic syndrome with monosomy 7 following combination therapy with granulocyte colony-stimulating factor, cyclosporin A and danazole in an adult patient with severe aplastic anemia].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1997, Volume: 38, Issue:9

    Topics: Adult; Anemia, Aplastic; Chromosomes, Human, Pair 7; Cyclosporine; Danazol; Female; Granulocyte Colony-Stimulating Factor; Humans; Immunosuppressive Agents; Monosomy; Myelodysplastic Syndromes

1997
Prolonged complete remission of myelodysplastic syndrome treated with danazol, retinoic acid and low-dose prednisone.
    American journal of hematology, 2000, Volume: 64, Issue:4

    Topics: Antineoplastic Agents; Danazol; Drug Therapy, Combination; Estrogen Antagonists; Female; Humans; Middle Aged; Myelodysplastic Syndromes; Prednisone; Remission Induction; Tretinoin

2000
Role of splenectomy in the treatment of myelodysplastic syndromes with peripheral thrombocytopenia: a report on six cases.
    Leukemia, 2001, Volume: 15, Issue:6

    Topics: Acute Disease; Adrenal Cortex Hormones; Adult; Aged; Anemia, Refractory; Anemia, Refractory, with Excess of Blasts; Autoimmune Diseases; Blood Platelets; Cellular Senescence; Cerebral Hemorrhage; Combined Modality Therapy; Danazol; Disease Progression; Female; Follow-Up Studies; Humans; Immunoglobulins, Intravenous; Interleukin-3; Leukemia, Myeloid; Leukemia, Myelomonocytic, Chronic; Male; Middle Aged; Myelodysplastic Syndromes; Neutropenia; Platelet Count; Recurrence; Retrospective Studies; Sjogren's Syndrome; Splenectomy; Thrombocytopenia; Treatment Outcome; Treatment Refusal; Vasculitis

2001
Remission of transformed myelodysplastic syndrome with fibrosis after danazol therapy.
    European journal of haematology, 2002, Volume: 68, Issue:4

    Topics: Aged; Danazol; Estrogen Antagonists; Humans; Male; Myelodysplastic Syndromes; Primary Myelofibrosis; Remission Induction

2002
Danazol: in vitro effects on human hemopoiesis and in vivo activity in hypoplastic and myelodysplastic disorders.
    European journal of haematology, 1991, Volume: 47, Issue:3

    Topics: Adult; Aged; Anemia, Aplastic; Bone Marrow; Bone Marrow Cells; Bone Marrow Transplantation; Cell Division; Cells, Cultured; Colony-Forming Units Assay; Danazol; Female; Hematopoiesis; Hematopoietic Stem Cells; Humans; Male; Megakaryocytes; Middle Aged; Myelodysplastic Syndromes; Reference Values

1991
Therapeutic efficacy of danazol in myelodysplastic syndromes.
    European journal of cancer & clinical oncology, 1988, Volume: 24, Issue:9

    Topics: Aged; Aged, 80 and over; Blood Transfusion; Danazol; Erythrocyte Count; Female; Hemoglobins; Humans; Male; Middle Aged; Myelodysplastic Syndromes; Platelet Count; Pregnadienes; Reticulocytes

1988
[Danazol in the treatment of acute leukemic transformation of myelodysplastic syndromes].
    Medicina clinica, 1987, Nov-21, Volume: 89, Issue:17

    Topics: Acute Disease; Aged; Danazol; Humans; Leukemia; Male; Myelodysplastic Syndromes; Pregnadienes

1987
Danazol and myelodysplastic syndromes.
    Annals of internal medicine, 1986, Volume: 104, Issue:3

    Topics: Danazol; Female; Humans; Middle Aged; Myelodysplastic Syndromes; Platelet Count; Pregnadienes

1986